The rise of Viagra initially fueled a boom for major pharmaceutical companies, but recent developments present a complicated outlook for shareholders. Off-patent competitors are eating into earnings, and ongoing https://sashambra307957.develop-blog.com/49059134/sildenafil-and-pharma-a-volatile-investment